Due to this regulatory effect on TNF, TAK1 has assumed importance as an interesting moiety for therapeutic intervention not only in TNF-associated maladies like autoimmune conditions (of the likes of rheumatoid arthritis, lupus, and IBD) but also other cytokine-related dysregulations like chronic pain and cancer [249]. This evidence concerns the gene TNF and rheumatoid arthritis.